Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 4/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 10/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.45 |
| ▸ | PTGIR | P43119 | 2/20 | 0.45 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.45 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | RXRG | P48443 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30185099 | 1.00 | CTSA (0.46) | CTSAPTGDR2CYP3A4CYP2C9TBXA2R | |
| SCHEMBL24985107 | 0.85 | CRHR1 (0.44) | CTSACYP3A4CYP2C9 | |
| SCHEMBL30185197 | 0.85 | CRHR1 (0.44) | CTSACYP3A4CYP2C9 | |
| SCHEMBL24985646 | 0.84 | CTSA (0.44) | CTSACYP3A4CYP2C9 | |
| SCHEMBL30185289 | 0.84 | CTSA (0.44) | CTSACYP3A4CYP2C9 | |
| SCHEMBL24984492 | 0.79 | CTSA (0.43) | CTSAPTGDR2CYP3A4CYP2C9MRGPRX4 | |
| SCHEMBL30185107 | 0.79 | CTSA (0.43) | CTSAPTGDR2CYP3A4CYP2C9MRGPRX4 | |
| SCHEMBL22366934 | 0.76 | NPSR1 (0.43) | CTSACYP3A4CYP2C9MRGPRX4 | |
| SCHEMBL24984549 | 0.76 | CTSA (0.47) | CTSACYP3A4CYP2C9MRGPRX4 | |
| SCHEMBL24985580 | 0.76 | MCL1 (0.41) | CTSACYP3A4CYP2C9MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230017045-A1 | PYRIDINE AND PYRIMIDINE CARBOXYLATE HERBICIDES AND METHODS OF USE THEREOF | DOW AGROSCIENCES LLC (US) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230017045-A1 | PYRIDINE AND PYRIMIDINE CARBOXYLATE HERBICIDES AND METHODS OF USE THEREOF | PDXK, DPYD, DDT | CTSA 4611/4885PTGDR2 2124/4885CYP3A4 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.